PTGX

Protagonist Therapeutics, Inc.

Healthcare›Biotechnology|NASDAQ Global Market|US

Price

$103.78

Market Cap

$6.62B

Beta

2.11

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)-89.41%

EPS Growth (YoY)-100.00%

Revenue CAGR 3Y+20.07%

P/E Ratio0.0

PEG Ratio—

FCF Yield+0.87%

Debt / Equity0.02

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for PTGX.